AS03-adjuvanted versus non-adjuvanted inactivated trivalent influenza vaccine against seasonal influenza in elderly people: a phase 3 randomised trial

This publication has 34 references indexed in Scilit:

• Safety and Long-term Humoral Immune Response in Adults After Vaccination With an H1N1 2009 Pandemic Influenza Vaccine With or Without AS03 Adjuvant
  The Journal of Infectious Diseases, 2012
• Dose-Sparing H5N1 A/Indonesia/05/2005 Pre-pandemic Influenza Vaccine in Adults and Elderly Adults: A Phase III, Placebo-Controlled, Randomized Study
  The Journal of Infectious Diseases, 2011
• Estimation of type- and subtype-specific influenza vaccine effectiveness in Victoria, Australia using a test negative case control method, 2007-2008
  BMC Infectious Diseases, 2011
• Effectiveness of Seasonal Vaccine in Preventing Confirmed Influenza-Associated Hospitalizations in Community Dwelling Older Adults
  The Journal of Infectious Diseases, 2011
• MF59™ as a vaccine adjuvant: a review of safety and immunogenicity
  Expert Review of Vaccines, 2010
• AS03_A‐Adjuvanted Influenza A (H1N1) 2009 Vaccine for Adults up to 85 Years of Age
  Clinical Infectious Diseases, 2010
• Immunogenicity and safety in adults of one dose of influenza A H1N1v 2009 vaccine formulated with and without AS03A-adjuvant: Preliminary report of an observer-blind, randomised trial
  Vaccine, 2010
• Influenza-Associated Hospitalizations in the United States
  JAMA, 2004
• A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation
  Journal of Chronic Diseases, 1987
• Guillain-Barré Syndrome and the 1978–1979 Influenza Vaccine
  New England Journal of Medicine, 1981